These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14642500)

  • 1. MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM).
    Hutchinson M; Raff U; Lebedev S
    Neuroimage; 2003 Nov; 20(3):1899-902. PubMed ID: 14642500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation.
    Raff U; Hutchinson M; Rojas GM; Huete I
    Acad Radiol; 2006 Jun; 13(6):721-7. PubMed ID: 16679274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Parkinson's disease by MRI: Spin-lattice distribution imaging.
    Hutchinson M; Raff U
    Mov Disord; 2008 Oct; 23(14):1991-7. PubMed ID: 18759364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Bukhatwa S; Zeng BY; Rose S; Jenner P
    Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer assessment of neurodegeneration in Parkinson disease using data fusion techniques with MR images.
    Raff U; Rojas GM; Huete I; Hutchinson M
    Acad Radiol; 2003 Sep; 10(9):1036-44. PubMed ID: 13678093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
    Hu MT; Scherfler C; Khan NL; Hajnal JV; Lees AJ; Quinn N; Wood NW; Brooks DJ
    Mov Disord; 2006 Mar; 21(3):299-305. PubMed ID: 16211589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.
    Talai AS; Ismail Z; Sedlacik J; Boelmans K; Forkert ND
    Clin Neuroradiol; 2019 Dec; 29(4):605-614. PubMed ID: 30218110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report.
    Araki K; Sumikura H; Matsudaira T; Sugiura A; Takao M; Murayama S; Obi T
    Neuropathology; 2016 Apr; 36(2):187-91. PubMed ID: 26388542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.
    Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C
    Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
    Reiter E; Mueller C; Pinter B; Krismer F; Scherfler C; Esterhammer R; Kremser C; Schocke M; Wenning GK; Poewe W; Seppi K
    Mov Disord; 2015 Jul; 30(8):1068-76. PubMed ID: 25773707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
    Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Coakeley S; Cho SS; Koshimori Y; Rusjan P; Ghadery C; Kim J; Lang AE; Houle S; Strafella AP
    Brain Struct Funct; 2018 Mar; 223(2):589-595. PubMed ID: 28884232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features.
    Oyanagi K; Tsuchiya K; Yamazaki M; Ikeda K
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):393-402. PubMed ID: 11305875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.
    Desai Bradaric B; Patel A; Schneider JA; Carvey PM; Hendey B
    J Neural Transm (Vienna); 2012 Jan; 119(1):59-71. PubMed ID: 21748523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ageing and Parkinson's disease: substantia nigra regional selectivity.
    Fearnley JM; Lees AJ
    Brain; 1991 Oct; 114 ( Pt 5)():2283-301. PubMed ID: 1933245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.